Applying Automated MR-Based Diagnostic Methods to the Memory Clinic: A Prospective Study.

Journal: Journal of Alzheimer's disease : JAD
PMID:

Abstract

Several studies have demonstrated that fully automated pattern recognition methods applied to structural magnetic resonance imaging (MRI) aid in the diagnosis of dementia, but these conclusions are based on highly preselected samples that significantly differ from that seen in a dementia clinic. At a single dementia clinic, we evaluated the ability of a linear support vector machine trained with completely unrelated data to differentiate between Alzheimer's disease (AD), frontotemporal dementia (FTD), Lewy body dementia, and healthy aging based on 3D-T1 weighted MRI data sets. Furthermore, we predicted progression to AD in subjects with mild cognitive impairment (MCI) at baseline and automatically quantified white matter hyperintensities from FLAIR-images. Separating additionally recruited healthy elderly from those with dementia was accurate with an area under the curve (AUC) of 0.97 (according to Fig. 4). Multi-class separation of patients with either AD or FTD from other included groups was good on the training set (AUC >  0.9) but substantially less accurate (AUC = 0.76 for AD, AUC = 0.78 for FTD) on 134 cases from the local clinic. Longitudinal data from 28 cases with MCI at baseline and appropriate follow-up data were available. The computer tool discriminated progressive from stable MCI with AUC = 0.73, compared to AUC = 0.80 for the training set. A relatively low accuracy by clinicians (AUC = 0.81) illustrates the difficulties of predicting conversion in this heterogeneous cohort. This first application of a MRI-based pattern recognition method to a routine sample demonstrates feasibility, but also illustrates that automated multi-class differential diagnoses have to be the focus of future methodological developments and application studies.

Authors

  • Stefan Klöppel
    Center of Geriatrics and Gerontology Freiburg, University Medical Center Freiburg, Freiburg, Germany.
  • Jessica Peter
    Freiburg Brain Imaging, University Medical Center Freiburg, Germany.
  • Anna Ludl
    Center of Geriatrics and Gerontology Freiburg, University Medical Center Freiburg, Freiburg, Germany.
  • Anne Pilatus
    Center of Geriatrics and Gerontology Freiburg, University Medical Center Freiburg, Freiburg, Germany.
  • Sabrina Maier
    Center of Geriatrics and Gerontology Freiburg, University Medical Center Freiburg, Freiburg, Germany.
  • Irina Mader
    Department of Neuroradiology, University Medical Center Freiburg, Freiburg, Germany.
  • Bernhard Heimbach
    Center of Geriatrics and Gerontology Freiburg, University Medical Center Freiburg, Freiburg, Germany.
  • Lars Frings
    Center of Geriatrics and Gerontology Freiburg, University Medical Center Freiburg, Freiburg, Germany.
  • Karl Egger
    Department of Neuroradiology, University Medical Center Freiburg, Freiburg, Germany.
  • Juergen Dukart
    F. Hoffmann-La Roche, pRED, Pharma Research and Early Development, DTA Neuroscience, Basel, Switzerland.
  • Matthias L Schroeter
    Max Planck Institute for Human Cognitive and Brain Sciences & Clinic for Cognitive Neurology, University of Leipzig, and German Consortium for Frontotemporal Lobar Degeneration, Ulm, Germany.
  • Robert Perneczky
    Neuroepidemiology and Ageing Research Unit, School of Public Health, Imperial College of Science, Technology and Medicine London, United Kingdom.
  • Peter Häussermann
  • Werner Vach
    Center for Medical Biometry and Medical Informatics, University of Freiburg, Germany.
  • Horst Urbach
    Department of Neuroradiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Stefan Teipel
    Departments of Psychosomatic Medicine, University of Rostock, and German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
  • Michael Hüll
    Center of Geriatrics and Gerontology Freiburg, University Medical Center Freiburg, Freiburg, Germany.
  • Ahmed Abdulkadir
    Laboratory for Research in Neuroimaging, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland.